Lux Research expects Optical Coherence Tomography (OCT), which currently has a market share of more than 60%, to remain dominant, expanding from ophthalmology into cardiology, oncology and gastroenterology. Alongside technologies such as near-infrared spectroscopy and photoacoustic tomography, the company’s analysts also forecast the market share of applications such as real-time optical biopsies and surgical guidance to increase.
“The growth of the optical imaging market will be fuelled by the OCT segment in the next five years, primarily because it has the clearest path to mass adoption,” said Milos Todorovic, Analyst, Lux Research.
“Over the long term, however, companies developing multimodal systems such as photoacoustics are attractive because they address larger markets,” added Todorovic.
